tirzepatide side effects 20 Possible Long-Term to Be Aware Of Mounjaro (Tirzepatide) Side Effects: What

Oprah Winfrey shares the type of weight loss medication she took Oprah Winfrey revealed on "The Oprah Podcast" that she took a GLP-1 agonist, a type of weight-loss medication, to help manage her weight

The Phase 3 TRIUMPH-4 data confirmed this trajectory

Central and peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors

We are here to provide the science-backed guidance and empathetic support you need to navigate every part of this process

Emerging antiobesity drugs in development Numerous novel treatments for obesity are currently in the pipeline, including triple agonists that target GLP-1, GIP, and glucagon receptors [26]

Moreover, like other medications in its class, there is a warning regarding the risk of thyroid C-cell tumors, based on animal studies, although its relevance to humans remains under investigation